125 related articles for article (PubMed ID: 23974730)
1. The end of the road for prostate specific antigen testing?
Nna E
Niger J Clin Pract; 2013; 16(4):407-17. PubMed ID: 23974730
[TBL] [Abstract][Full Text] [Related]
2. Current biomarkers for diagnosing of prostate cancer.
Stephan C; Jung K; Ralla B
Future Oncol; 2015; 11(20):2743-55. PubMed ID: 26358139
[TBL] [Abstract][Full Text] [Related]
3. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
[TBL] [Abstract][Full Text] [Related]
4. Molecular prostate cancer pathology: current issues and achievements.
Schalken JA; Bergh A; Bono A; Foster C; Gospadarowicz M; Isaacs WB; Rubin M; Schröder F; Tribukait B; Tsukamotot T; Wiklund P
Scand J Urol Nephrol Suppl; 2005 May; (216):82-93. PubMed ID: 16019760
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in localized prostate cancer.
Ferro M; Buonerba C; Terracciano D; Lucarelli G; Cosimato V; Bottero D; Deliu VM; Ditonno P; Perdonà S; Autorino R; Coman I; De Placido S; Di Lorenzo G; De Cobelli O
Future Oncol; 2016 Feb; 12(3):399-411. PubMed ID: 26768791
[TBL] [Abstract][Full Text] [Related]
6. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen screening: pro.
Loeb S; Catalona WJ
Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
[TBL] [Abstract][Full Text] [Related]
8. Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer.
Heger Z; Gumulec J; Ondrak A; Skoda J; Zitka Z; Cernei N; Masarik M; Zitka O; Adam V
Int J Mol Sci; 2016 Mar; 17(3):377. PubMed ID: 26999116
[TBL] [Abstract][Full Text] [Related]
9. Advances in biomarkers for the early diagnosis of prostate cancer.
Cao DL; Yao XD
Chin J Cancer; 2010 Feb; 29(2):229-33. PubMed ID: 20109357
[TBL] [Abstract][Full Text] [Related]
10. Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine.
Cao DL; Ye DW; Zhu Y; Zhang HL; Wang YX; Yao XD
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):166-72. PubMed ID: 21321584
[TBL] [Abstract][Full Text] [Related]
11. Urine markers in monitoring for prostate cancer.
Jamaspishvili T; Kral M; Khomeriki I; Student V; Kolar Z; Bouchal J
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):12-9. PubMed ID: 19652665
[TBL] [Abstract][Full Text] [Related]
12. Emerging biomarkers for the diagnosis and prognosis of prostate cancer.
Sardana G; Dowell B; Diamandis EP
Clin Chem; 2008 Dec; 54(12):1951-60. PubMed ID: 18927246
[TBL] [Abstract][Full Text] [Related]
13. [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
Mazzola CR; Ghoneim T; Shariat SF
Prog Urol; 2011 Jan; 21(1):1-10. PubMed ID: 21193139
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
Duffy MJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):310-6. PubMed ID: 21525152
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of prostate cancer.
Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
Salagierski M; Schalken JA
J Urol; 2012 Mar; 187(3):795-801. PubMed ID: 22245323
[TBL] [Abstract][Full Text] [Related]
17. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
Lin DW
Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
[TBL] [Abstract][Full Text] [Related]
18. Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer.
Coelho FF; Guimarães FL; Cabral WL; Salles PG; Mateo EC; Nogueira e Nogueira LM; Fonseca CE; Gomes KB
Genet Mol Res; 2015 Oct; 14(4):13519-31. PubMed ID: 26535666
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM
Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen.
Fradet Y
Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
